Welcome to our dedicated page for Synchrony Financial SEC filings (Ticker: SYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Synchrony Financial (SYF) filed a Form 144 indicating a planned disposition of 709 common shares, valued at $48,176.55. The shares were acquired on 08/01/2025 via restricted-stock vesting as compensation and represent roughly 0.0002 % of the 372,057,548 shares outstanding. The proposed sale is slated for on or after 08/04/2025 through Fidelity Brokerage Services on the NYSE. No other sales by the filer occurred in the past three months, and the signer affirmed no undisclosed adverse information. Because the identity of the seller and any Rule 10b5-1 plan details are not provided, the filing appears to be a routine, low-value insider transaction with negligible effect on SYF’s float, liquidity, or fundamentals.
Synchrony Financial (SYF) has filed a Form 144 indicating the proposed sale of 600 common shares by an insider. The shares, acquired through restricted-stock vesting on 01 Aug 2025, are planned to be sold around 04 Aug 2025 via Fidelity Brokerage Services on the NYSE. The aggregate market value of the block is $40,770, implying a reference price of roughly $67.95 per share. With 372.1 million shares outstanding, the transaction represents 0.0002 % of total shares — a de-minimis level that is unlikely to alter the company’s float or insider ownership profile.
No other sales were reported in the past three months, and no material adverse information was disclosed in the filing. This notice simply satisfies Rule 144 requirements, providing advance public disclosure of the insider’s intent to sell recently vested equity compensation.